On ECHEMI
Home > Drugs > Empagliflozin Registered Holders
Empagliflozin structure

Empagliflozin structure

Empagliflozin

Empagliflozin is a selective sodium glucose cotransporter-2 (SGLT-2) inhibitor with an IC50 of 3.1 nM for human SGLT-2.

Find 82 Related Holders

CHEMO SMS ENTERPRISE SL
United States United States

API Registration Country

API Active
ALP PHARM BEIJING CO LTD
United States United States

API Registration Country

API Active
CTX LIFESCIENCES PVT LTD
United States United States

API Registration Country

API Active
BEIJING HUIKANG BOYUAN CHEMICAL TECH CO LTD
United States United States

API Registration Country

API Active
ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
Sun Pharmaceutical Industries Ltd
United States United States

API Registration Country

API Active
FUXIN LONG RUI PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
EMNAR PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
SICHUAN KELUN PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
JIANGXI SYNERGY PHARMACEUTICAL CO LTD
United States United States

API Registration Country

API Active
Recommended Suppliers of Empagliflozin
View 138 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.